Fundraising Fox
Ivenix
Amesbury, US · Delaware corporation · 1,812 employees on LinkedIn · 5 known investors
Find your way into Ivenix
Sign up to see every warm intro you have to Ivenix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ivenix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors. The system is designed for nursing staff, pharmacists, IT departments, clinical engineers, and anesthesia professionals in healthcare facilities.
Founders & leadership
Board
Investors · 5
How we know: Cardinal Partners's portfolio page · prnewswire.com · Not right? Tell us
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$52.3M disclosed across 3 rounds · 2015–2017
▶$10MraisedMar 2017 · 18 investors · BiotechnologyRule 506(b)
- George GrayExecutive Officer
- John ClarkeDirector
- John DouglassDirector
- Stuart RandleExecutive Officer, Director
- John WuDirector
- Jesse AmbrosinaExecutive Officer
- Ketan PatelDirector
- Wei LiDirector
- Offering amount
- $50M
- Amount sold
- $10M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$27.5MraisedSep 2015 · 25 investors · BiotechnologyRule 506(b)
- John SokolowskiExecutive Officer
- Darrell CrateDirector
- George GrayExecutive Officer
- John DouglassDirector
- Carolyn MalleckExecutive Officer
- Jesse AmbrosinaExecutive Officer
- Offering amount
- $27.5M
- Amount sold
- $27.5M
- Sales commissions
- $756.1K
- Placement agents
- Leerink Partners LLC
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$14.8MraisedSep 2015 · 43 investors · BiotechnologyRule 506(b)
- Ketan PatelDirector
- John M. DouglassDirector
- John SokolowskiExecutive Officer
- John K. ClarkeDirector
- Jesse AmbrosinaExecutive Officer
- Colin J. FosterDirector
- Wayne B. WeismanDirector
- Darrell J. CrateDirector
- George W. GrayExecutive Officer
- Carolyn MalleckExecutive Officer
- Offering amount
- $14.8M
- Amount sold
- $14.8M
- First sale
- Aug 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Ivenix.
In the news
Frequently asked questions
- What does Ivenix do?
- Ivenix makes an intelligent infusion pump system for hospital settings that delivers intravenous medications to patients while incorporating safeguards to reduce medication errors. The system is designed for nursing staff, pharmacists, IT departments, clinical engineers, and anesthesia professionals in healthcare facilities.
- Who are Ivenix's investors?
- Ivenix's investors include Cardinal Partners, F-Prime Capital, SCP Vitalife Partners, ECO Fleet Holdings, WuXi Healthcare Ventures.
- How much funding has Ivenix raised?
- Ivenix has disclosed $52.3M raised across 3 rounds.
- Where is Ivenix headquartered?
- Ivenix is headquartered in Amesbury, US.